Physician profile
Basil Saour
NPI 1407171853
$21,329.81
in general payments reported to CMS, 2019-2025
35 companies · $5,946 in 2025
The $5,946 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,430 · 2020: $66.66 · 2021: $2,833 · 2022: $3,550 · 2023: $3,290 · 2024: $4,215 · 2025: $5,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,706 · Travel and Lodging: $4,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,705.93 |
| Travel and Lodging | $4,743.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,967.93 | 2019-2025 | Aveir, Cardiomems, Ensite |
| Biosense Webster, INC. | $3,872.88 | 2019-2025 | Carto 3, Qdot Micro, Soundstar |
| Boston Scientific Corporation | $2,460.81 | 2019-2025 | Watchman Access System, Farapulse, General - Therapies |
| Medtronic, INC. | $1,786.94 | 2021-2024 | Pulseselect, Na, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $1,596.87 | 2021-2025 | Xarelto, Uptravi |
| Medtronic Vascular, INC. | $821.22 | 2019 | |
| Novo Nordisk INC | $574.73 | 2021-2025 | Ozempic |
| Biotronik INC. | $407.72 | 2021-2022 | |
| Amgen INC. | $393.78 | 2021-2025 | Repatha, Repatha |
| Abiomed | $373.56 | 2021-2025 | Impella |
| Impulse Dynamics (USA) INC. | $349.81 | 2022-2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.11 | 2021-2023 | Jardiance |
| Acutus Medical, INC. | $211.55 | 2019 | |
| Novartis Pharmaceuticals Corporation | $161.52 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $124.08 | 2022-2025 | Camzyos, Eliquis |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $114.07 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astrazeneca Pharmaceuticals Lp | $95.71 | 2021 | |
| Cook Medical LLC | $79.34 | 2024 | Cook, Evolution |
| Edwards Lifesciences Corporation | $73.23 | 2023-2025 | Hemosphere, Pascal |
| Clariance, INC. | $72.79 | 2023 | Entire Product Portfolio |
| Heartflow, INC. | $60.05 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $50.69 | 2023-2024 | Assure Wcd |
| Shockwave Medical, INC | $50.60 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $45.90 | 2025 | |
| Terumo Medical Corporation | $38.61 | 2021 | |
| Scpharmaceuticals INC. | $34.84 | 2023-2024 | |
| Philips North America LLC | $25.06 | 2023 | |
| Cvrx, INC. | $23.23 | 2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $22.51 | 2025 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.70 | 2025 | Lifevest |
| Chiesi USA, INC. | $19.02 | 2025 | Kengreal |
| Livanova USA, INC. | $18.63 | 2023 | Lifesparc |
| Inspire Medical Systems, INC. | $18.43 | 2023 | Inspire |
| Merck Sharp & Dohme LLC | $17.61 | 2021 | |
| Surmodics, INC. | $14.28 | 2023 | Pounce Thrombectomy, Pounce Venous Thrombectomy System, Pounce Thrombectomy System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Basil Saour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.